On 5/12/2008
poppy/cath wrote:
Memorial Sloan-Kettering investigators are also studying sorafenib (Nexavar®) for use in multiple myeloma patients with abnormal kidney function. An oral multiple kinase inhibitor that affects tumor growth and angiogenesis (blood vessel formation), sorafenib stops cancer cells from producing a signal that is necessary for their multiplication, according to research findings.
This came from the Sloan Kettering site and I'm interested because of my recent kidney problems. I'd like to talk to anyone who has been using Nexavar about their experiences with this drug. Any help gratefully appreciated. Many thanks, Cath
I am taking Nexavar for liver cancer. It is supose to stop the growth of tumors by blocking the blood supply. I have been taking it since September. Side effects aren't nice, but my tumor hasn't grown. Actually I don't know for sure if it would have without the medicine or not. I found out in July 2007, had two chemoembolizations to the liver in August. Then started Nexavar in September. I was told that chemo doesn't work for primary liver tumors so I'm taking this instead. It was first used for kidney cancer then they tried it on liver cancer and it helped a lot of people so they quit the trials so they could let everyone have access to the medicine.
Sue